As mass spectrometry makes inroads into pathogen identification in the clinical laboratory, deep sequencing—even nanopore sequencing—is waiting in the wings. Jeffrey L. Fox investigates.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Doughty, E.L. et al. PeerJ 2, e585 (2014).
Wilson, M.R. et al. N. Engl. J. Med. 370, 2408–2417 (2014).
Loman, N.J. et al. J. Am. Med. Assoc. 309, 1502–1510 (2013).
Conlan, S. et al. Sci. Transl. Med. 6, 254ra126 (2014).
FDA Public Workshop. Advancing Regulatory Science for High Throughput Sequencing Devices for Microbial Identification and Detection of Antimicrobial Resistance Markers. Silver Spring, Maryland, April 1, 2014.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Technology comes to typing. Nat Biotechnol 32, 1081–1084 (2014). https://doi.org/10.1038/nbt.3067
Published:
Issue date:
DOI: https://doi.org/10.1038/nbt.3067
